COMP <GO>
IMVT vs KOD // ALTMAN Z-SCORE & DEBT/EQUITY
Immunovant Inc. (NASDAQ) VS. Kodiak Sciences Inc (NASDAQ) • 15-METRIC TALLY: IMVT 4
— KOD 6
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: IMVT
LAST: $29.04 (+2.22%) • MKT CAP: $5.87B
balance-sheet
26.00
LAST: $98.89 (+1.30%) • MKT CAP: $6.14B
balance-sheet
16.70
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMVT VS. KOD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IMVT | KOD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.65% | -2.16% | -4.49 | KOD | /fcf-yield <GO> |
| Operating Margin | -36.00% | -13.30% | -22.70 | KOD | /operating-margins <GO> |
| Net Profit Margin | -29.50% | -13.00% | -16.50 | KOD | /net-margins <GO> |
| Revenue Growth (YoY) | 9.90% | 1.10% | +8.80 | IMVT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 26.00 | 16.70 | +9.30 | IMVT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | IMVT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.4 | 63.0 | -26.60 | KOD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 0.90 | +0.08 | IMVT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 35.0x | +1.00 | KOD | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.87B | $6.14B | -$267.5M | KOD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IMVT REV | KOD REV | IMVT GROSS % | KOD GROSS % | IMVT FCF | KOD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.67B | $656.3M | — | — | -$407.3M | -$136.5M |
| FY 2024 | $1.37B | $523.2M | — | — | -$376.6M | -$117.7M |
| FY 2023 | $856.8M | $776.5M | — | — | -$214.2M | -$154.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMVT // BETA 0.98
KOD // BETA 0.90